Cambridge Innovation Institute Announces the Acquisition of Evaluating Biopharma
Networking and Educational Event Series Join Cambridge Innovation Institute's Extensive Portfolio NEEDHAM, Mass., July 14, 2022 /PRNewswire/ -- Cambridge Innovation...
Networking and Educational Event Series Join Cambridge Innovation Institute's Extensive Portfolio NEEDHAM, Mass., July 14, 2022 /PRNewswire/ -- Cambridge Innovation...
NORTH CHARLESTON, S.C., July 14, 2022 /PRNewswire/ -- CMS Imaging, Inc., a leading Independent Sales and Service Organization, has signed...
Nephron Pharmaceuticals Corporation selects Revaly as their design collaboration tool. WEST COLUMBIA, S.C., July 14, 2022 /PRNewswire/ -- ZVerse, an...
MELBOURNE, Australia, July 14, 2022 /PRNewswire/ -- A Qualitative Research Study accomplished by Data Bridge Market research's database of 350...
Quantitative biomarkers of demyelination can improve clinical trial design and accelerate development of disease-modifying therapeutics SAN FRANCISCO, July 14, 2022...
DURBAN, South Africa, July 14, 2022 /PRNewswire/ -- "Global Life Science Software Market" the new research report adds in Data Bridge...
BERLIN, July 14, 2022 /PRNewswire/ -- Recent study report released by Data Bridge Market research with titled "Global Total Lab Automation Market" (covering...
ZUG, Switzerland, July 14, 2022 (GLOBE NEWSWIRE) -- Covis Pharma Group (the “Company”), a global specialty pharmaceutical company that markets...
NANJING, China, July 13, 2022 /PRNewswire/ -- On July 13, 2022, Triastek, Inc. ("Triastek") announced a collaboration with Eli Lilly...
WALTHAM, Mass., July 14, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in...
- Horizon Platform Originates Record $192 Million of New Loans in Q2, Including $137 Million of New Loans for HRZN...
Vancouver, British Columbia--(Newsfile Corp. - July 14, 2022) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" the "Company"), a...
Demonstrates OBDS Device Performance and Bioavailability in Animal ModelsSAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq:...
Chiesi’s Annual and Sustainability Report 2021 is released today;Progress toward business, environmental and social targets is strong;Company is joining forces...
Excellent Safety and Tolerability Profile for iNexin™ for the Treatment of Corneal Injury Early Efficacy Signals Provide Rationale to Advance...
Los Angeles, CA, July 14, 2022 (GLOBE NEWSWIRE) -- MDbio are a leading plant-based, wellness solution who provide safe, pharmaceutical-grade...
KELOWNA, British Columbia, July 14, 2022 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to...
In the TENAYA and LUCERNE studies, more than 60% of Vabysmo patients could be treated every four months at two...
Strengthens balance sheet with non-dilutive capital at an attractive cost Competitive process results in the sale of 30% of the...
SOUTH SAN FRANCISCO, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced the...